Ono Koji, Kondo Yuya, Ichikawa Takuma, Asada Yasuki
Graduate School of Health Sciences, Fujita Health University.
Faculty of Radiological Technology, School of Health Sciences, Fujita Health University (Current address: Graduate School of Health Sciences, Fujita Health University).
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(7):556-562. doi: 10.6009/jjrt.2017_JSRT_73.7.556.
The first diagnostic reference levels (DRLs 2015) in Japan were published in June 2015. The purpose of this study was to compare the calculated entrance surface doses with the values of DRLs 2015, and evaluate differences in patient exposure among facilities. Semiconductor dosimeter was installed, and dosimetry was performed using equipment and radiographic condition of each facility. As a result, a dose higher than the value of DRLs 2015 was used in 12 kinds of examination. In child chest examination, the doses of the three facilities (0.26 mGy, 0.28 mGy, 0.60 mGy) exceeded the value of DRLs 2015 (0.2 mGy). Review of the radiographic condition is necessary because the doses exceeding DRLs 2015 tended to have a high current time product. The examination with the largest difference between facilities was the lateral of thoracic spine, with a difference of about 46 times, and the examination with the smallest difference was the ankle joint, with a difference of about three times. When reviewing, it is necessary to focus mainly on examinations that have a large difference between facilities. In the future, it can be said that it is necessary to set diagnostic reference range (DRR) or achievable dose (AD) to understand how high or low dose of the own facility are compared with facilities nationwide.
日本的首个诊断参考水平(2015年诊断参考水平)于2015年6月发布。本研究的目的是将计算出的体表入射剂量与2015年诊断参考水平的值进行比较,并评估各机构之间患者受照剂量的差异。安装了半导体剂量仪,并使用各机构的设备和射线照相条件进行剂量测定。结果,在12种检查中使用了高于2015年诊断参考水平值的剂量。在儿童胸部检查中,三家机构的剂量(0.26 mGy、0.28 mGy、0.60 mGy)超过了2015年诊断参考水平的值(0.2 mGy)。由于超过2015年诊断参考水平的剂量往往具有较高的电流时间乘积,因此有必要对射线照相条件进行审查。各机构之间差异最大的检查是胸椎侧位,相差约46倍,差异最小的检查是踝关节,相差约3倍。审查时,有必要主要关注各机构之间差异较大的检查。未来,可以说有必要设定诊断参考范围(DRR)或可实现剂量(AD),以了解自己机构的剂量与全国范围内各机构相比是高还是低。